Divozilimab (Anti-CD20)

Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20) with the potential to be used in multiple sclerosis research. MW : 145.26 KD.

Price Not Available 1mg*5 Divozilimab (Anti-CD20) Supplier Page
Trivial name BCD-132
Catalog Number A2823
CAS# 2254061-60-2
Size 1mg*5